NAT10 is critical to block RNA sensing-induced IFN-β transactivation in viral infection
mBio · 2026
DOI: 10.1128/mbio.01452-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2026. Verfasst von Youngmin Park und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Interferon-beta, Transcriptional Activation, Acetyltransferases, RNA Virus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Cells detect invading viruses and produce type I interferons (IFNs) to stimulate an innate antiviral effector response. However, IFN levels must be fine-tuned to achieve antiviral efficacy while limiting hyperinflammatory and tissue-damaging effects. Here, we report that NAT10, a histone and cytidine acetyltransferase, regulates the production of type I IFNs and RNA virus infections. Depletion of NAT10 increased the expression of IFN-β and IFN-stimulated genes, and correspondingly impaired viral replication. Mechanistically, NAT10 dynamically associated with the IFN-β promoter and also negatively regulated IRF3’s chromatin associations through modulation of long noncoding RNAs that inhibit IRF3. Treatment of cells with Remodelin, a NAT10 inhibitor, similarly increased IFN-β expression and inhibited viral infections. Overall, our findings reveal NAT10 is a potential host-directed target for antiviral treatment via regulation of type I IFN. IMPORTANCE Type I interferons (IFNs) signaling pathway is critical to cellular defense and innate immunity against evading pathogens, including viruses. However, induction of type I IFNs is fine-tuned to achieve the antiviral consequence while maintaining host cellular homeostasis. This paper presents a novel mechanism for the NAT10 protein to silence IFN-β induction through modulation of IRF3 activity at the promoter of IFN-β, and further demonstrates the therapeutic potential of the NAT10 inhibitor Remodelin to restrict viral infection while inducing IFN-β.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
- Department of Microbiology, College of Arts and Sciences, The Ohio State University, Columbus, Ohio, USA.
- Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Yan Liu, Jacob S Yount, Netty G Santoso, Jian Zhu
Förderung
- NIMH NIH HHS
- NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NIDA NIH HHS
- National Institutes of Health
Zitieren
APA
Park, Y., Liu, Y., He, J., Eleya, S., Wu, Z., Fiches, G. N., Zhou, D., Watters, E. G., He, Z. M., Shanaka, K. A. S. N., Lepcha, T. T., Yount, J. S., Santoso, N. G., & Zhu, J. (2026). NAT10 is critical to block RNA sensing-induced IFN-β transactivation in viral infection. mBio. https://doi.org/10.1128/mbio.01452-26
Vancouver
Park Y, Liu Y, He J, Eleya S, Wu Z, Fiches GN, et al. NAT10 is critical to block RNA sensing-induced IFN-β transactivation in viral infection. mBio. 2026. doi:10.1128/mbio.01452-26
BibTeX
@article{Park2026,
author = {Park, Youngmin and Liu, Yan and He, Jinshan and Eleya, Suha and Wu, Zhenyu and Fiches, Guillaume Nicolas and Zhou, Dawei and Watters, Emily G and He, Zhixian M and Shanaka, Kateepe Arachchige Sudeera Nuwan and Lepcha, Thurbu Tshering and Yount, Jacob S and Santoso, Netty G and Zhu, Jian},
title = {NAT10 is critical to block RNA sensing-induced IFN-β transactivation in viral infection},
journal = {mBio},
year = {2026},
doi = {10.1128/mbio.01452-26}
}
EUVIMED